A look at Codex DNA Inc.’s (DNAY) recent performance gives investors their first glimpse of hope.

On June 22, 2022, Codex DNA Inc. (NASDAQ: DNAY) opened at $2.71, lower -3.74% from the last session. During the day, the shares moved up to $2.90 and dropped to $2.05 before settling in for the closing price of $2.14. Price fluctuations for DNAY have ranged from $2.11 to $25.70 over the past 52 weeks.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Company’s average yearly earnings per share was noted -247.00% at the time writing. With a float of $18.52 million, this company’s outstanding shares have now reached $29.33 million.

The firm has a total of 264 workers. Let’s measure their productivity. In terms of profitability, gross margin is +24.68, operating margin of -320.33, and the pretax margin is -352.66.

Codex DNA Inc. (DNAY) Insider Activity

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Codex DNA Inc. is 0.40%, while institutional ownership is 59.30%.

Codex DNA Inc. (DNAY) Earnings and Forecasts

If we go through the results of last quarter, which was made public on 3/30/2022, the company posted -$0.45 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.43) by -$0.02. This company achieved a net margin of -352.78 while generating a return on equity of -119.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -247.00% per share during the next fiscal year.

Codex DNA Inc. (NASDAQ: DNAY) Trading Performance Indicators

Check out the current performance indicators for Codex DNA Inc. (DNAY). In the past quarter, the stock posted a quick ratio of 5.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.29.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.52, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.66 in one year’s time.

Technical Analysis of Codex DNA Inc. (DNAY)

Analysing the last 5-days average volume posted by the [Codex DNA Inc., DNAY], we can find that recorded value of 2.59 million was better than the volume posted last year of 0.4 million. As of the previous 9 days, the stock’s Stochastic %D was 3.52%. Additionally, its Average True Range was 0.41.

During the past 100 days, Codex DNA Inc.’s (DNAY) raw stochastic average was set at 0.11%, which indicates a significant decrease from 0.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.43% in the past 14 days, which was lower than the 129.34% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.83, while its 200-day Moving Average is $7.57. Now, the first resistance to watch is $2.62. This is followed by the second major resistance level at $3.19. The third major resistance level sits at $3.47. If the price goes on to break the first support level at $1.77, it is likely to go to the next support level at $1.49. Should the price break the second support level, the third support level stands at $0.92.

Codex DNA Inc. (NASDAQ: DNAY) Key Stats

There are currently 29,398K shares outstanding in the company with a market cap of 61.80 million. Presently, the company’s annual sales total 11,040 K according to its annual income of -38,960 K. Last quarter, the company’s sales amounted to 5,640 K and its income totaled -13,190 K.


Citigroup Upgraded Nokia Oyj (NOK) To Buy with Price Target of $6.8

Nokia Oyj (NYSE: NOK), a communications equipment developer, is...

The Chart for Block Inc. (SQ) Stock Is Flashing Mixed Signals

In the first quarter, large investment funds expanded their...

What to Expect When Snap Inc. (SNAP) Reports Quarterly Earnings?

Snapchat, a social media platform owned by Snap Inc....

Getting Sustainable Earnings? Movado Group Inc. (MOV)

Movado Group Inc. (NYSE: MOV), the owner of the...



Don't miss

Chevron Corporation (CVX) provides details about its hydrogen future

The huge hydrogen investment plan of the oil and...

Healthy Upside Potential: Maxar Technologies Ltd. (MAXR)

In May 25 trading, shares of space business Maxar...

Atkore Inc. (ATKR) stock: Better Than You Think

Atkore Inc. (NYSE:ATKR), a manufacturer of infrastructure, electrical, and...

Provention Bio, Inc. (PRVB) Having a Robust Premarket After Abysmal Thursday

Provention Bio, Inc. (PRVB), a clinical stage biopharmaceutical company,...

$1.28M in average volume shows that Luokung Technology Corp. (LKCO) is heading in the right direction

On June 30, 2022, Luokung Technology Corp. (NASDAQ: LKCO) opened at $0.40, lower -4.10% from the last session. During the day, the shares moved...

Recent developments with Duke Realty Corporation (DRE) have led to the company’s beta value being reach 0.67 cents.

A new trading day began on June 30, 2022, with Duke Realty Corporation (NYSE: DRE) stock priced at $55.02, down -0.72% from the previous...

Campbell Soup Company (CPB) posted a 1.37% change over the last five days signaling a new trend

Campbell Soup Company (NYSE: CPB) kicked off on June 30, 2022, at the price of $48.30, down -0.72% from the previous trading day. During...


Please enter your comment!
Please enter your name here




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam